Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities.

ABSTRACT: Although radiotherapy continues to evolve as a mainstay of the oncological armamentarium, research and innovation in radiotherapy in low-income and middle-income countries (LMICs) faces challenges. This third Series paper examines the current state of LMIC radiotherapy research and provides new data from a 2022 survey undertaken by the International Atomic Energy Agency and new data on funding. In the context of LMIC-related challenges and impediments, we explore several developments and advances-such as deep phenotyping, real-time targeting, and artificial intelligence-to flag specific opportunities with applicability and relevance for resource-constrained settings. Given the pressing nature of cancer in LMICs, we also highlight some best practices and address the broader need to develop

SUBMITTER: Abdel-Wahab M 

PROVIDER: S-EPMC11382686 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature